Grace Therapeutics (GRCE) Revenue & Revenue Breakdown
Grace Therapeutics Revenue Highlights
00
Grace Therapeutics Revenue by Period
Grace Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-03-31 | $196.00K | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-02-29 | $27.79K | -87.15% |
| 2015-02-28 | $216.29K | -51.95% |
| 2014-02-28 | $450.16K | -36.36% |
| 2013-02-28 | $707.39K | 6653.17% |
| 2012-02-29 | $10.47K | -63.93% |
| 2011-02-28 | $29.04K | 100.00% |
| 2010-02-28 | - | - |
Grace Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Grace Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $8.00K | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $115.00K | 41.98% |
| 2020-12-31 | $81.00K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | -100.00% |
| 2016-11-30 | $936.33 | 100.00% |
| 2016-08-31 | - | -100.00% |
| 2016-05-31 | $2.21K | -85.14% |
| 2016-02-29 | $14.90K | 292.75% |
| 2015-11-30 | $3.79K | -28.20% |
| 2015-08-31 | $5.29K | 27.45% |
| 2015-05-31 | $4.15K | -96.94% |
| 2015-02-28 | $135.60K | 439.00% |
| 2014-11-30 | $25.16K | 262.84% |
| 2014-08-31 | $6.93K | -86.58% |
| 2014-05-31 | $51.68K | -69.01% |
| 2014-02-28 | $166.75K | 524.55% |
| 2013-11-30 | $26.70K | -89.42% |
| 2013-08-31 | $252.47K | 3973.46% |
| 2013-05-31 | $6.20K | -77.53% |
| 2013-02-28 | $27.58K | -93.54% |
| 2012-11-30 | $427.16K | 78.75% |
| 2012-08-31 | $238.97K | 1703.03% |
| 2012-05-31 | $13.25K | -10.50% |
| 2012-02-29 | $14.81K | 100.00% |
| 2011-11-30 | - | 100.00% |
| 2011-08-31 | - | -100.00% |
| 2011-05-31 | $84.94K | 192.51% |
| 2011-02-28 | $29.04K | 100.00% |
| 2010-11-30 | - | 100.00% |
| 2010-08-31 | - | 100.00% |
| 2010-05-31 | - | 100.00% |
| 2010-02-28 | - | 100.00% |
| 2009-11-30 | - | - |
Grace Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.